Marisol Ruiz-Meana Selected Research

4,17 beta-dihydroxy-4-androstene-3-one

5/2013	Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
12/2011	Effects of a reduction in the number of gap junction channels or in their conductance on ischemia-reperfusion arrhythmias in isolated mouse hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marisol Ruiz-Meana Research Topics

Disease

27	Infarction (Infarctions) 05/2024 - 01/2002
24	Ischemia 05/2024 - 09/2002
17	Reperfusion Injury 01/2020 - 07/2003
11	Coronary Occlusion 04/2024 - 01/2002
9	Myocardial Ischemia (Ischemic Heart Diseases) 05/2024 - 04/2003
8	Myocardial Infarction 04/2024 - 04/2009
7	ST Elevation Myocardial Infarction 01/2023 - 01/2016
7	Hypoxia (Hypoxemia) 01/2022 - 06/2003
7	Acidosis 01/2019 - 09/2002
5	Rupture 10/2009 - 10/2004
4	Necrosis 11/2007 - 09/2002
3	Ventricular Remodeling 04/2024 - 01/2020
3	Cardiomegaly (Heart Hypertrophy) 04/2022 - 10/2011
3	Hypertrophy 12/2021 - 10/2011
3	Thrombosis (Thrombus) 01/2020 - 01/2016
3	Contracture 11/2011 - 04/2003
2	Cicatrix (Scar) 04/2024 - 01/2020
2	Fibrosis (Cirrhosis) 01/2024 - 12/2021
2	Heart Failure 01/2024 - 12/2019
2	Edema (Dropsy) 01/2023 - 10/2004
2	Diabetic Cardiomyopathies 07/2021 - 01/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2024
1	Infections 01/2023
1	Inflammation (Inflammations) 01/2023
1	Endotoxemia 01/2023
1	Sepsis (Septicemia) 01/2023
1	Left Ventricular Dysfunction 01/2023
1	Cardiomyopathies (Cardiomyopathy) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Iron Deficiencies 07/2021
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

7	Connexin 43 (Connexin43)IBA 01/2020 - 08/2005
7	Adenosine Triphosphate (ATP)IBA 01/2019 - 09/2002
6	malonic acid (malonate)IBA 05/2024 - 03/2016
5	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2024 - 03/2016
5	CalciumIBA 10/2021 - 09/2006
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2016 - 09/2003
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 07/2006
4	Succinic Acid (Succinate)IBA 05/2024 - 11/2017
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2002
4	CalpainIBA 04/2022 - 10/2004
4	P-SelectinIBA 01/2020 - 09/2002
4	Mitochondrial Permeability Transition PoreIBA 01/2020 - 05/2006
3	triphenyltetrazoliumIBA 04/2024 - 11/2003
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2024 - 10/2004
3	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 06/2003
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 11/2011
3	FibrinIBA 01/2020 - 01/2016
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2017 - 08/2004
3	Diazoxide (Hyperstat)FDA Link 05/2013 - 07/2006
3	fluorexon (calcein)IBA 11/2011 - 09/2006
2	C.I. direct red 80IBA 04/2024 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2021 - 03/2020
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 05/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 09/2002
2	Exenatide (Byetta)FDA Link 01/2021 - 07/2015
2	afimoxifene (hydroxytamoxifen)IBA 01/2020 - 12/2011
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
2	LipidsIBA 09/2017 - 01/2016
2	Insulin (Novolin)FDA Link 07/2015 - 05/2014
2	4,17 beta-dihydroxy-4-androstene-3-oneIBA 05/2013 - 12/2011
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2009 - 09/2003
2	Atrial Natriuretic Factor (ANF)IBA 02/2009 - 06/2003
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2007 - 05/2006
2	Heptanol (1 Heptanol)IBA 02/2006 - 08/2004
2	cariporideIBA 09/2003 - 04/2003
1	TRPC6 Cation ChannelIBA 01/2024
1	CalcineurinIBA 01/2024
1	transcription factor NF-AT c3IBA 01/2024
1	ABR-238901IBA 01/2023
1	AlarminsIBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	calpain inhibitorsIBA 04/2022
1	Janus KinasesIBA 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2021
1	CollagenIBA 12/2021
1	Advanced Glycation End ProductsIBA 10/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2021
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 07/2021
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2021
1	IronIBA 07/2021
1	malic acid (malate)IBA 04/2021
1	FumaratesIBA 04/2021
1	SodiumIBA 04/2021
1	5- (6'- triphenylphosphoniumhexyl)- 5,6- dihydro- 6- phenyl- 3,8- phenanthridinediammineIBA 01/2018
1	Plasminogen Activator Inhibitor 1IBA 09/2017
1	Dialysis SolutionsIBA 01/2017
1	Glycine Receptors (Glycine Receptor)IBA 01/2017
1	von Willebrand FactorIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	PalmitatesIBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015

Therapy/Procedure

9	Therapeutics 01/2023 - 04/2013
4	Ischemic Postconditioning 05/2014 - 02/2009
3	Percutaneous Coronary Intervention 07/2021 - 01/2020
2	Ligation 04/2024 - 09/2003
1	Catheters 01/2020
1	Aftercare (After-Treatment) 01/2015